|
| | | | |
|
 | | NEW CEO AT CEVEC PHARMACEUTICALS GMBH | | | CEVEC Pharmaceuticals GmbH | | 02/10/2008 | | | CEVEC Pharmaceuticals, a biopharmaceutical company specializing in the development of complex therapeutic proteins using their proprietary human cell expression systems, appointed Rainer Lichtenberger Ph.D., MBA as the new Chief Executive Officer (CEO). Rainer Lichtenberger will replace Prof. Stefan Kochanek, one of the founders of the company, who led the company as interim CEO for nearly half a year and will continue to serve as one of the advisory board members.
With Dr. Lichtenberger, CEVEC has attracted a seasoned life science manager with 20 years of management experience in renowned companies such as the Merckle/ratiopharm group and Merck KGaA. There he held various positions of increasing responsibility, among them vice-president of strategic marketing and corporate vice-president of business development. Most recently, he led a private venture-financed German biopharmaceutical development company, where he managed a major series A venture round. Dr. Lichtenberger’s team at CEVEC will be complemented by other experienced staff such as Dr. Christoph Volpers, Chief Operating Officer (COO) and Chief Scientific Officer (CSO) Dr. Gudrun Schiedner.
Gangolf Ehlen, Investment Manager for Venture Capital Investments of Sparkasse KölnBonn and chairman of the advisory board of CEVEC comments: "We are very satisfied that we could win Dr. Lichtenberger as a senior expert with broad and deep industry experience and excellent business networks. We see this as further proof of the attractiveness of CEVEC's unique technology platform. We would like to thank Prof. Kochanek for his commitment in this transition period of the company." Prof. Kochanek said: "I am looking forward to working with Dr. Lichtenberger, whose background in drug development, business development and experience in a venture financed life science company fits perfectly into CEVEC’s ambitious business objectives for the next few years. | |
|
| | | View similar articles: | | |
| | | |
|
 | People who viewed this article were also interested in |  | |  |
|